AACR StoriesThe Faces & Voices Behind the Science

Using funding from the AACR, early-career investigator Marco Ruella, MD, found a way to improve immunotherapy for B-cell acute lymphoblastic leukemia.

Preventing cancer and identifying malignancies at the earliest, most treatable stages are key areas of focus for the American Association for Cancer Research (AACR) and its members.

Pioneering chemist and Fellow of the AACR Academy Carolyn R. Bertozzi, PhD, leads efforts to develop cancer therapeutics against “a different type of drug target.”